2,6-Dihydroxy-3-cyanopyridine

Catalog No.: 
ACZTFE825
CAS No.: 
35441-10-2
Molecular Formula: 
C6H4N2O2
Molecular Weight: 
136.11
2,6-Dihydroxy-3-cyanopyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g95%$120.00In stockIn stock
10g95%$239.00In stockIn stock
25g95%$534.00In stockInquiry
100g95%$1634.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,6-Dihydroxy-3-cyanopyridine
IUPAC Name2,6-dihydroxynicotinonitrile
MDL No.MFCD11558977
Molecular FormulaC6H4N2O2
Molecular Weight136.11
SMILESN#CC1=CC=C(O)N=C1O
InChI KeyBFHKYHMCIAMQIN-UHFFFAOYSA-N
Synonym2-hydroxy-6-oxo-1,6-dihydropyridine-3-carbonitrile | 2,6-Dihydroxy-3-cyanopyridine;3-Cyano-2,6-dihydroxypyridine | Q-101510 | 2,6-Dihydroxy-3-cyanopyridine | 2,6-dihydroxynicotinonitrile | 3-Cyano-2,6-dihydroxypyridine | FT-0624465 | 3-Pyridinecarbonitril
CAS No.35441-10-2
PubChem CID100608

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACZTFE825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZTFE825 route product structure diagram
    ACZTFE82535441-10-2In Stock
Inquiry

2. ACZTFE825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZTFE825 route product structure diagram
    ACZTFE82535441-10-2In Stock
Inquiry

3. ACZTFE825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZTFE825 route product structure diagram
    ACZTFE82535441-10-2In Stock
Inquiry

Comments (0)